Combination chemotherapy for clinically established graft-versus-host disease in mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004357:Drug Synergism; D006087:Graft vs Host Reaction / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use; D013154:Spleen / Q000637:transplantation*; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D001565:Benzoates; D011344:Procarbazine; D003520:Cyclophosphamide; D003348:Cortisone